Infrared Ray Heat Treatment in Liver Cirrhosis Patients With Refractory Ascites
NCT ID: NCT01558895
Last Updated: 2012-03-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2/PHASE3
40 participants
INTERVENTIONAL
2012-03-31
2013-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Using Infrared Spectroscopy for Diagnosis Severity of Nonalcoholic Fatty Liver Disease
NCT02860884
Microwave Ablation Versus Liver Resection For Early Hepatocellular Carcinoma in Patients With Borderline Liver Function
NCT03766555
Radiomics for Diagnosing Liver Diseases and Evaluating Progression
NCT03221049
TIPS Combined With Microwave Ablation in HCC Patients With Refractory Ascites
NCT04640116
Thermal Imaging in Liver Disease.
NCT03279419
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Conventional Treatment and Infrared ray heat treatment group
conventional treatment consist of antiviral drugs, lowering aminotransferase and jaundice medicine.
Infrared ray heat treatment
Patients in experimental group accepted Infrared ray heat treatment in hepatic area for 30 minutes as well as conventional therapy.
conventional treatment group
conventional treatment consist of antiviral drugs, lowering aminotransferase and jaundice medicine.
conventional treatment
Conventional treatment consists of antiviral drugs, lowering aminotransferase and jaundice medicine.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Infrared ray heat treatment
Patients in experimental group accepted Infrared ray heat treatment in hepatic area for 30 minutes as well as conventional therapy.
conventional treatment
Conventional treatment consists of antiviral drugs, lowering aminotransferase and jaundice medicine.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* aged 18\~60 years
* inpatient
* Diagnosed with liver cirrhosis and liver stubborn ascites.
Exclusion Criteria
* combined with malignant tumour.
* combined with endocrine diseases.
* combined with high fever.
* infected with the AIDS virus
18 Years
60 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
First People's Hospital of Foshan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yinong Ye
Professor and Chief
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yinong Ye, doctor
Role: PRINCIPAL_INVESTIGATOR
First People's Hospital of Foshan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The first people's hospital of Foshan
Foshan, Guangdong, China
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FS-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.